ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 426 filers reported holding ISHARES TR in Q3 2015. The put-call ratio across all filers is 1.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,556,228 | -4.0% | 20,903 | -0.4% | 0.00% | 0.0% |
| Q2 2023 | $2,663,874 | +8.6% | 20,982 | +10.5% | 0.00% | 0.0% |
| Q1 2023 | $2,452,232 | -2.4% | 18,986 | -0.8% | 0.00% | 0.0% |
| Q4 2022 | $2,513,678 | +10.6% | 19,146 | -1.5% | 0.00% | 0.0% |
| Q3 2022 | $2,273,000 | -1.3% | 19,436 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $2,304,000 | -11.7% | 19,586 | -2.2% | 0.00% | 0.0% |
| Q1 2022 | $2,610,000 | -16.0% | 20,026 | -1.7% | 0.00% | 0.0% |
| Q4 2021 | $3,107,000 | -4.4% | 20,362 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $3,249,000 | +10.7% | 20,100 | +12.1% | 0.00% | 0.0% |
| Q2 2021 | $2,936,000 | +19.9% | 17,938 | +10.3% | 0.00% | 0.0% |
| Q1 2021 | $2,448,000 | +2.6% | 16,263 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $2,385,000 | +7.5% | 15,741 | -4.0% | 0.00% | 0.0% |
| Q3 2020 | $2,219,000 | +48.0% | 16,391 | +55.4% | 0.00% | 0.0% |
| Q2 2020 | $1,499,000 | +638.4% | 10,546 | +1657.7% | 0.00% | – |
| Q4 2015 | $203,000 | -8.1% | 600 | 0.0% | 0.00% | – |
| Q2 2015 | $221,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |